Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy
Phase 2
Completed
- Conditions
- Peripheral Diabetic Neuropathy
- Registration Number
- NCT06131918
- Lead Sponsor
- Khyber Medical University Peshawar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients with Type 2 Diabetes Mellitus<br><br> - Age between 40-60 years<br><br>Exclusion Criteria:<br><br> - Malignancy<br><br> - Vitamin B12 deficiency<br><br> - History of drug or alcohol abuse<br><br> - Taking antioxidant treatment<br><br> - History and baseline investigations for renal hepatic and haematological diseases<br><br> - Pregnant or lactating women.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in nerve conduction latency, velocity and amplitude.;Change in clinical symptoms of neuropathy.
- Secondary Outcome Measures
Name Time Method levels of superoxide radical anion,;Levels of Malonaldehyde oxidative stress biomarker;Levels of Superoxide dismutase and Glutathione peroxidase